Independent validation of a predictive risk model for contrast-enhancing brain lesions supports enhanced periventricular radiosensitivity and variable proton RBE
Publication date: Available online 15 November 2026 Source: Radiotherapy and Oncology Author(s): Julia Bauer, Tanja Adena-Eichkorn, Lia Velkova, Jürgen Debus, Laila König, Semi Harrabi
Independent validation of a predictive risk model for contrast-enhancing brain lesions supports enhanced periventricular radiosensitivity and variable proton RBE. // Radiotherapy & Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0167814026045421?dgcid=rss_sd_all
Independent validation of a predictive risk model for contrast-enhancing brain lesions supports enhanced periventricular radiosensitivity and variable proton RBE. Radiotherapy & Oncology. https://www.sciencedirect.com/science/article/pii/S0167814026045421?dgcid=rss_sd_all
“Independent validation of a predictive risk model for contrast-enhancing brain lesions supports enhanced periventricular radiosensitivity and variable proton RBE.” Radiotherapy & Oncology.
@article{article95046,
title = {Independent validation of a predictive risk model for contrast-enhancing brain lesions supports enhanced periventricular radiosensitivity and variable proton RBE},
journal = {Radiotherapy \& Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0167814026045421?dgcid=rss_sd_all}
}